{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:17:20Z","timestamp":1792451840198,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["TTK20110727000022309"],"award-info":[{"award-number":["TTK20110727000022309"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.humimm.2022.01.014","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T08:08:09Z","timestamp":1645517289000},"page":"399-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["The acidic tumour microenvironment: Manipulating the immune response to elicit escape"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-4828","authenticated-orcid":false,"given":"Catherine M.","family":"Worsley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob B.","family":"Veale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Mayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41416-020-01172-1","article-title":"The fibrotic and immune microenvironments as targetable drivers of metastasis","volume":"124","author":"Boulter","year":"2021","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0010","doi-asserted-by":"crossref","first-page":"152729","DOI":"10.1016\/j.prp.2019.152729","article-title":"Tumor microenvironment components: allies of cancer progression","volume":"216","author":"Ribeiro Franco","year":"2020","journal-title":"Pathol Res Pract"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10555-014-9531-3","article-title":"Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy","volume":"33","author":"Fais","year":"2014","journal-title":"Cancer Metastasis Rev"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/ijms20040840","article-title":"Targeting tumor microenvironment for cancer therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humimm.2022.01.014_b0025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41419-020-03175-5","article-title":"Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy","volume":"11","author":"Cerezo","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1-2","key":"10.1016\/j.humimm.2022.01.014_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10555-019-09783-8","article-title":"Extracellular acidity and increased exosome release as key phenotypes of malignant tumors","volume":"38","author":"Logozzi","year":"2019","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-physiol-021119-034627","article-title":"The Acidic tumor microenvironment as a driver of cancer","volume":"82","author":"Boedtkjer","year":"2020","journal-title":"Annu Rev Physiol"},{"issue":"11","key":"10.1016\/j.humimm.2022.01.014_b0045","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.3390\/cancers12113226","article-title":"The acidic microenvironment: is it a phenotype of all cancers? a focus on multiple myeloma and some analogies with diabetes mellitus","volume":"12","author":"Fais","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.humimm.2022.01.014_b0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.37349\/etat.2020.00005","article-title":"The impact of tumour pH on cancer progression: strategies for clinical intervention","volume":"1","author":"Ward","year":"2020","journal-title":"Explor Target Anti-tumor Ther"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.it.2015.02.007","article-title":"T cell metabolic fitness in antitumor immunity","volume":"36","author":"Siska","year":"2015","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0060","doi-asserted-by":"crossref","first-page":"e13068","DOI":"10.1111\/apha.13068","article-title":"Roles of pH in control of cell proliferation","volume":"223","author":"Flinck","year":"2018","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.humimm.2022.01.014_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.canlet.2020.12.021","article-title":"The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment","volume":"500","author":"Hayes","year":"2021","journal-title":"Cancer Lett"},{"issue":"19","key":"10.1016\/j.humimm.2022.01.014_b0070","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1038\/s41388-019-0688-7","article-title":"Lactate modulates CD4(+) T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis","volume":"38","author":"Comito","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.humimm.2022.01.014_b0075","doi-asserted-by":"crossref","first-page":"108500","DOI":"10.1016\/j.celrep.2020.108500","article-title":"Lactate limits T cell proliferation via the NAD(H) redox state","volume":"33","author":"Quinn","year":"2020","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0080","first-page":"254","article-title":"Emerging roles of lipid metabolism in cancer progression","volume":"20","author":"Corbet","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7","key":"10.1016\/j.humimm.2022.01.014_b0085","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.bbadis.2018.04.019","article-title":"Acidic pHe regulates cytoskeletal dynamics through conformational integrin beta1 activation and promotes membrane protrusion","volume":"1864","author":"Li","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0090","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-019-14262-3","article-title":"TGFbeta2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells","volume":"11","author":"Corbet","year":"2020","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.humimm.2022.01.014_b0095","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/15384101.2016.1176394","article-title":"Lysosomal protein relocation as an adaptation mechanism to extracellular acidosis","volume":"15","author":"Damaghi","year":"2016","journal-title":"Cell Cycle"},{"issue":"1-2","key":"10.1016\/j.humimm.2022.01.014_b0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10555-019-09787-4","article-title":"Acidosis and cancer: from mechanism to neutralization","volume":"38","author":"Ibrahim-Hashim","year":"2019","journal-title":"Cancer Metastasis Rev"},{"issue":"16","key":"10.1016\/j.humimm.2022.01.014_b0105","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1158\/0008-5472.CAN-11-3881","article-title":"Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments","volume":"72","author":"Wojtkowiak","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0110","doi-asserted-by":"crossref","DOI":"10.1186\/2049-3002-1-23","article-title":"Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress","volume":"1","author":"LaMonte","year":"2013","journal-title":"Cancer & Metabolism"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78955-2","article-title":"Differential metabolic responses in breast cancer cell lines to acidosis and lactic acidosis revealed by stable isotope assisted metabolomics","volume":"10","author":"Gao","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.humimm.2022.01.014_b0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/cells8070727","article-title":"Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis","volume":"8","author":"Doyle","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0125","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s13277-015-3230-8","article-title":"Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts","volume":"36","author":"Han","year":"2015","journal-title":"Tumour Biol"},{"issue":"19","key":"10.1016\/j.humimm.2022.01.014_b0130","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.7150\/jca.21780","article-title":"Cellular interactions in the tumor microenvironment: the role of secretome","volume":"10","author":"da Cunha","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.humimm.2022.01.014_b0135","doi-asserted-by":"crossref","first-page":"104972","DOI":"10.1016\/j.oraloncology.2020.104972","article-title":"Portrait of a CAF: the story of cancer-associated fibroblasts in head and neck cancer","volume":"110","author":"Cust\u00f3dio","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.humimm.2022.01.014_b0140","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","article-title":"The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses","volume":"11","author":"Labani-Motlagh","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3171\/2008.10.17672","article-title":"Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features","volume":"111","author":"Korhonen","year":"2009","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.humimm.2022.01.014_b0150","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1073\/pnas.0804543106","article-title":"Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR","volume":"106","author":"Al-Nedawi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"10.1016\/j.humimm.2022.01.014_b0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcancer.2018.06.002","article-title":"The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer","volume":"52","author":"Missiaen","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"10.1016\/j.humimm.2022.01.014_b0160","doi-asserted-by":"crossref","first-page":"e104453","DOI":"10.1371\/journal.pone.0104453","article-title":"Infiltration of alternatively activated macrophages in cancer tissue is associated with MDSC and Th2 polarization in patients with esophageal cancer","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.semcancer.2012.02.005","article-title":"Recent advances on the role of tumor exosomes in immunosuppression and disease progression","volume":"22","author":"Filipazzi","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.humimm.2022.01.014_b0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mehy.2015.12.007","article-title":"Myeloid-derived suppressor cells (MDSC) facilitate distant metastasis of malignancies by shielding circulating tumor cells (CTC) from immune surveillance","volume":"87","author":"Liu","year":"2016","journal-title":"Med Hypotheses"},{"issue":"16","key":"10.1016\/j.humimm.2022.01.014_b0175","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1158\/0008-5472.CAN-04-0465","article-title":"Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses","volume":"64","author":"Rodriguez","year":"2004","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.humimm.2022.01.014_b0180","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-17-0691","article-title":"Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing Fc receptor-mediated natural killer cell function","volume":"24","author":"Stiff","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humimm.2022.01.014_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","article-title":"Fates of CD8+ T cells in tumor microenvironment","volume":"17","author":"Maimela","year":"2019","journal-title":"Comput Struct Biotechnol J"},{"issue":"2","key":"10.1016\/j.humimm.2022.01.014_b0190","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10753-020-01373-z","article-title":"Motility and mechanical properties of dendritic cells deteriorated by extracellular acidosis","volume":"44","author":"Tong","year":"2021","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0195","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"18","key":"10.1016\/j.humimm.2022.01.014_b0200","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"issue":"45","key":"10.1016\/j.humimm.2022.01.014_b0205","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.humimm.2022.01.014_b0210","first-page":"1","article-title":"Tumor-associated macrophages and neutrophils in tumor microenvironment","volume":"2016","author":"Kim","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"8","key":"10.1016\/j.humimm.2022.01.014_b0215","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3390\/cancers13081850","article-title":"Recruitment and expansion of Tregs cells in the tumor environment-how to target them?","volume":"13","author":"Cinier","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2022.01.014_b0220","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2020.00532","article-title":"An attempt to polarize human neutrophils toward N1 and N2 phenotypes in vitro","volume":"11","author":"Ohms","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humimm.2022.01.014_b0230","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.4049\/jimmunol.162.8.4849","article-title":"Extracellular Acidification induces human neutrophil activation","volume":"162","author":"Trevani","year":"1999","journal-title":"J Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.humimm.2022.01.014_b0235","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.thromres.2018.01.049","article-title":"Platelets, NETs and cancer","volume":"164","author":"Cedervall","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.humimm.2022.01.014_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-35723-8_1","article-title":"Neutrophils in the tumor microenvironment","volume":"1224","author":"Wu","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0245","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.it.2019.01.006","article-title":"Neutrophil degranulation, plasticity, and cancer metastasis","volume":"40","author":"Mollinedo","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/j.humimm.2022.01.014_b0250","first-page":"1","article-title":"Tumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspective","volume":"2017","author":"Chen","year":"2017","journal-title":"J Immunol Res"},{"issue":"9","key":"10.1016\/j.humimm.2022.01.014_b0255","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/ijc.30646","article-title":"Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-gamma and induces NK cell-dependent lymphoma control without other immunotherapies","volume":"140","author":"Potzl","year":"2017","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semcancer.2012.02.009","article-title":"Tumor metabolism as modulator of immune response and tumor progression","volume":"22","author":"Gottfried","year":"2012","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/j.humimm.2022.01.014_b0265","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1158\/2326-6066.CIR-18-0481","article-title":"Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident NK cells in colorectal liver metastasis","volume":"7","author":"Harmon","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.humimm.2022.01.014_b0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.humimm.2022.01.014_b0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcell.2020.00017","article-title":"T cell dysfunction and exhaustion in cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.humimm.2022.01.014_b0280","first-page":"4032","article-title":"Th17 cells associated cytokines and cancer","volume":"20","author":"Feng","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0285","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/imm.12917","article-title":"Hypoxia and acidosis: immune suppressors and therapeutic targets","volume":"154","author":"Damgaci","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2022.01.014_b0290","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cytogfr.2017.04.003","article-title":"Dysfunctional T cell metabolism in the tumor microenvironment","volume":"35","author":"Beckermann","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.humimm.2022.01.014_b0295","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55185","article-title":"The tumor microenvironment as a metabolic barrier to effector T cells and immunotherapy","volume":"9","author":"Lim","year":"2020","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0300","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ijc.26410","article-title":"Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK\/c-Jun activation","volume":"131","author":"Mendler","year":"2012","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.humimm.2022.01.014_b0305","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/1521-4141(200109)31:9<2829::AID-IMMU2829>3.0.CO;2-U","article-title":"Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7\/CD28 costimulation","volume":"31","author":"Bosticardo","year":"2001","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15698\/cst2019.01.171","article-title":"Regulation of T cell antitumor immune response by tumor induced metabolic stress","volume":"3","author":"Chalmin","year":"2018","journal-title":"Cell Stress"},{"issue":"11","key":"10.1016\/j.humimm.2022.01.014_b0315","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.humimm.2022.01.014_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.589434","article-title":"Tumor lactic acidosis: protecting tumor by inhibiting cytotoxic activity through motility arrest and bioenergetic silencing","volume":"10","author":"Fischbeck","year":"2020","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.humimm.2022.01.014_b0325","doi-asserted-by":"crossref","first-page":"e1016700","DOI":"10.1080\/2162402X.2015.1016700","article-title":"Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells","volume":"4","author":"Wu","year":"2015","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/ijms21010157","article-title":"Tumor Microenvironment: a metabolic player that shapes the immune response","volume":"21","author":"Cassim","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0335","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1586\/1744666X.2014.865519","article-title":"Cellular and molecular mechanisms in cancer immune escape: a comprehensive review","volume":"10","author":"Bhatia","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"7851","key":"10.1016\/j.humimm.2022.01.014_b0340","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0345","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41423-018-0027-x","article-title":"Tumor-infiltrating B cells: their role and application in anti-tumor immunity in lung cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0350","doi-asserted-by":"crossref","first-page":"1535293","DOI":"10.1080\/2162402X.2018.1535293","article-title":"Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma","volume":"8","author":"Lechner","year":"2019","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.humimm.2022.01.014_b0355","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/intimm\/dxv034","article-title":"Regulatory B cells in anti-tumor immunity","volume":"27","author":"Zhang","year":"2015","journal-title":"Int Immunol"},{"issue":"5","key":"10.1016\/j.humimm.2022.01.014_b0360","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/cells8050449","article-title":"The B-side of Cancer immunity: the underrated tune","volume":"8","author":"Largeot","year":"2019","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.humimm.2022.01.014_b0365","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/cmi.2017.35","article-title":"B cell regulation in cancer and anti-tumor immunity","volume":"14","author":"Sarvaria","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.humimm.2022.01.014_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2017.02.008","article-title":"Yin-yang effect of tumor infiltrating B cells in breast cancer: from mechanism to immunotherapy","volume":"393","author":"Zhang","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.humimm.2022.01.014_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.582657","article-title":"Phenotypes, Functions, and clinical relevance of regulatory B Cells in Cancer","volume":"11","author":"Shang","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.humimm.2022.01.014_b0380","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.humimm.2022.01.014_b0385","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.4049\/jimmunol.1201920","article-title":"Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator-activated receptor \u03b1","volume":"190","author":"Wejksza","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.humimm.2022.01.014_b0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.747780","article-title":"Indoleamine 2, 3-dioxygenase promotes aryl hydrocarbon receptor-dependent differentiation of regulatory B cells in lung cancer","volume":"12","author":"Tousif","year":"2021","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.humimm.2022.01.014_b0395","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","article-title":"Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells","volume":"71","author":"Olkhanud","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.humimm.2022.01.014_b0400","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.1007\/s13277-015-4538-0","article-title":"Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients","volume":"37","author":"Wei","year":"2016","journal-title":"Tumor Biology"},{"issue":"6","key":"10.1016\/j.humimm.2022.01.014_b0405","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of tumor acidity improves antitumor responses to immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.humimm.2022.01.014_b0410","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1158\/1078-0432.CCR-20-0113","article-title":"Low-dose metformin reprograms the tumor immune microenvironment in human esophageal cancer: results of a phase II clinical trial","volume":"26","author":"Wang","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"6024","key":"10.1016\/j.humimm.2022.01.014_b0415","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"issue":"7738","key":"10.1016\/j.humimm.2022.01.014_b0420","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0425","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-018-0403-1","article-title":"Targeting VEGFR2 with Ramucirumab strongly impacts effector\/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment","volume":"6","author":"Tada","year":"2018","journal-title":"J Immunother Cancer"},{"issue":"10","key":"10.1016\/j.humimm.2022.01.014_b0430","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc.2017.77","article-title":"Tumour acidosis: from the passenger to the driver's seat","volume":"17","author":"Corbet","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.humimm.2022.01.014_b0435","doi-asserted-by":"crossref","first-page":"1800366","DOI":"10.1002\/mabi.201800366","article-title":"Acetazolamide-loaded pH-responsive nanoparticles alleviating tumor acidosis to enhance chemotherapy effects","volume":"19","author":"Liu","year":"2019","journal-title":"Macromol Biosci"},{"issue":"8","key":"10.1016\/j.humimm.2022.01.014_b0440","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1021\/acs.molpharmaceut.1c00085","article-title":"Reversing hypoxia with PLGA-encapsulated manganese dioxide nanoparticles improves natural killer cell response to tumor spheroids","volume":"18","author":"Murphy","year":"2021","journal-title":"Mol Pharm"},{"issue":"28","key":"10.1016\/j.humimm.2022.01.014_b0445","doi-asserted-by":"crossref","first-page":"7429","DOI":"10.1039\/D0SC00293C","article-title":"A tumor acidity activatable and Ca(2+)-assisted immuno-nanoagent enhances breast cancer therapy and suppresses cancer recurrence","volume":"11","author":"Li","year":"2020","journal-title":"Chem Sci"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0450","doi-asserted-by":"crossref","first-page":"e22058","DOI":"10.4161\/onci.22058","article-title":"The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors","volume":"2","author":"Bellone","year":"2013","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0455","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/metabo8010002","article-title":"Rethinking the combination of proton exchanger inhibitors in cancer therapy","volume":"8","author":"Iessi","year":"2017","journal-title":"Metabolites"},{"issue":"22","key":"10.1016\/j.humimm.2022.01.014_b0460","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1158\/0008-5472.CAN-12-1772","article-title":"The V-ATPase-inhibitor archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1","volume":"72","author":"Wiedmann","year":"2012","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.humimm.2022.01.014_b0465","doi-asserted-by":"crossref","first-page":"9476","DOI":"10.18632\/oncotarget.14339","article-title":"V-ATPase inhibition increases cancer cell stiffness and blocks membrane related Ras signaling \u2013 a new option for HCC therapy","volume":"8","author":"Bartel","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2022.01.014_b0470","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-014-0277-x","article-title":"The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis","volume":"14","author":"Nelson","year":"2015","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0475","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3892\/ijo.2015.3239","article-title":"Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells","volume":"48","author":"Mohammed","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humimm.2022.01.014_b0480","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2017.01.006","article-title":"Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer","volume":"43","author":"Koltai","year":"2017","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0485","article-title":"Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cancer"},{"issue":"24","key":"10.1016\/j.humimm.2022.01.014_b0490","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.18632\/oncotarget.11299","article-title":"Tumor-reducing effect of the clinically used drug clofazimine in a SCID mouse model of pancreatic ductal adenocarcinoma","volume":"8","author":"Zaccagnino","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0495","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/02656736.2013.858832","article-title":"Thermal sensitisation by lonidamine of human melanoma cells grown at low extracellular pH","volume":"30","author":"Coss","year":"2014","journal-title":"Int J Hyperthermia"},{"issue":"7","key":"10.1016\/j.humimm.2022.01.014_b0500","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1042\/BJ20151120","article-title":"The anti-tumour agent lonidamine is a potent inhibitor of the mitochondrial pyruvate carrier and plasma membrane monocarboxylate transporters","volume":"473","author":"Nancolas","year":"2016","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.humimm.2022.01.014_b0505","doi-asserted-by":"crossref","first-page":"16804","DOI":"10.1038\/s41598-018-35103-1","article-title":"Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters","volume":"8","author":"Mehibel","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.humimm.2022.01.014_b0510","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.humimm.2022.01.014_b0515","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/ijms20051208","article-title":"Novel 8-substituted coumarins that selectively inhibit human carbonic anhydrase IX and XII","volume":"20","author":"Buran","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"15","key":"10.1016\/j.humimm.2022.01.014_b0520","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1016\/j.bmcl.2009.06.002","article-title":"The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms","volume":"19","author":"Parkkila","year":"2009","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922000301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885922000301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:55:08Z","timestamp":1759319708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885922000301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0198885922000301"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2022.01.014","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The acidic tumour microenvironment: Manipulating the immune response to elicit escape","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2022.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}